Interaction of a new depolymerized holothurian glycosaminoglycan with proteins in human plasma

Thrombosis Research

Volumn 83, Issue 3, 1996, Pages 253-264

  Minamiguchi, Kazuhisa ^a   Nagase, Hideki ^a   Kitazato, Keiko T ^a   Kitazato, Kenji ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

anticoagulant; depolymerized holothurian glycosaminoglycan; glycosaminoglycan; protein binding

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 9; GLYCOSAMINOGLYCAN; HEPARIN; HOLOTHURIN; PLASMINOGEN; PROTEIN C; PROTEIN S; THROMBOCYTE FACTOR 4; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BINDING AFFINITY; BLEEDING; BLEEDING TIME; DRUG EFFECT; DRUG PROTEIN BINDING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030220082     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00134-X     Document Type: Article

References (30)

1. SUZUKI N., KITAZATO K., TAKAMATSU J., SAITO H. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka. Thromb Haemostas. 65:1991;369-373.
2. YOSHIDA K., MINAMI Y., NEMOTO H., NUMATA K., YAMANAKA E. Structure of DHG, a depolymerized glycosaminoglycan from sea cucumber, Stichopus japonicus. Tetrahedron Lett. 33:1992;4959-4962.
3. NAGASE H., ENJYOJI K., MINAMIGUCHI K., KITAZATO K.T., KITAZATO K., SAITO H., KATO H. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions : Antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Blood. 85:1995;1527-1534.
4. MANT M.J., O'BRIEN B.D., THONG K.L., HAMMOND G.W., BIRTWHISTLE R.V., GRACE G.C. Haemorrhagic complications of heparin therapy. Lancet. 1:1977;1133-1135.
5. SALZMAN E.W., DEYKIN D., SHAPIRO R.M., ROSENBERG R.D. Management of heparin therapy - Controlled prospective trial. N Engl J Med. 292:1975;1046-1050.
6. MCKAY E.J., LAURELL C.B. The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III. J Lab Clin Med. 95:1980;69-80.
7. LANE, D.A. Heparin binding and neutralizing proteins. In: Heparin, Chemical and Biological Properties, Clinical Applications. D.A. Lane and U. Lindahl (eds.), pp. 363-391, CRC Press, Boca Raton (1989).
8. ZAMMIT A., PEPPER D.S., DAWES J. Interaction of immobilized unfractionated and LMW heparins with proteins in whole human plasma. Thromb Haemostas. 70:1993;951-958.
9. HIRSH J., LEVINE M.N. Low molecular weight heparin. Blood. 79:1992;1-17.
10. DEJANA E., VILLA S., DE GAETANO G. Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemostas. 48:1982;108-111.
11. OUCHTERLONY, Ö. Gel diffusion techniques. In: Immunological Methods J.F. Ackroyd (ed.), p. 55, Blackwell Sci Publ, Oxford (1964).
12. LAEMMLI U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
13. MILLER M.A., PALASCAK J.E., THOMPSON M.R., MARTELO O.J. A modified SDS agarose gel method for determining factor VIII von Willebrand factor multimers using commercially available reagent. Thromb Res. 39:1985;777-790.
14. NAGASE H., ENJYOJI K., SHIMA M., KITAZATO K., YOSHIDA A., SAITO H., KATO H. Effect of depolymerized holothurian glycosaminoglycan (DHG) on the activation of factor VIII and factor V by thrombin. J Biochem. 119:1996;63-69.
15. KITAZATO, K., KITAZATO, K.T., NAGASE, H., MINAMIGUCHI, K. and SAITO, H. DHG, a new depolymerized holothurian glycosaminoglycan, exerts an antithrombotic effect with less bleeding than unfractionated or low molecular weight heparin, in rats. in preparation.
16. MAFFRAND J.P., HERBERT J.M., BERNAT A., DEFREYN G., DELEBASSEE D., SAVI P., PINOT J.J., SAMPOL J. Experimental and clinical pharmacology of pentosan polysulfate. Semin Throm Hemost. 17:1991;186-198.
17. BJORK I., LINDAHL U. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem. 48:1982;161-182.
18. CARTER C.J., KELTON J.G., HIRSH J., CERSKUS A., SANTOS A.V., GENT M. The relationship between the hemorrhagic and antithrombotic properties of low molecular heparin in rabbits. Blood. 59:1982;1239-1245.
19. FERNANDEZ F., VAN, RYN J., OFOSU F.A., HIRSH J., BUCHANAN M.R. The hemorrhagic and antithrombotic effects of dermatan sulphate. Br J Haematol. 64:1986;309-317.
20. FERNANDEZ F., N'GUYEN P., VAN, RYN J., OFOSU F.A., HIRSH J., BUCHANAN M.R. Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thromb Res. 43:1986;491-495.
21. SOBEL M., MCNEILL P.M., CARISON P.L., KERMODE J.C., ADELMAN B., CONROY R., MARQUES D. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest. 87:1991;1787-1793.
22. RUGGERI Z.M., ZIMMERMAN T.S. von Willebrand factor and von Willebrand disease. Blood. 70:1987;895-904.
23. RUGGERI Z.M., ZIMMERMAN T.S. Classification of von Willebrand disease. J Clin Lab Anal. 1:1987;353-362.
24. CHRISTOPHE, DE ROMEUF, CLAUDINE MAZURIER Heparin binding assay of von Willebrand factor (vWF) in plasma milieu - Evidence of the importance of the multimerization degree of vWF. Thromb Haemostas. 69:1993;436-440.
25. PALM M., MATTSSON C., SVAHN C.M., WEBER M. Bleeding times in rats treated with heparin, heparin fragments of high and low anticoagulant activity and chemically modified heparin fragments of low anticoagulant activity. Thromb Haemostas. 64:1990;127-132.
26. MAGGI A., ABBADINI M., PAGELLA P.G., BOROWSKA A., PANGRAZZI J., DONATI M.B. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model. Haemostasis. 17:1987;329-335.
27. HANDIN R.I., COHEN H.J. Purification and binding properties of human platelet factor 4. J Biol Chem. 251:1976;4273-4282.
28. DENTON J., LANE D.A., THUNBERG L., SLATER A.M., LINDAHL U. Binding of platelet factor 4 to heparin oligosaccharides. Biochem J. 209:1983;455-460.
29. LANE D.A., DENTON J., FLYNN A.M., THUNBERG L., LINDAHL U. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J. 218:1984;725-732.
30. LANE D.A., PEJLER G., FLYNN A.M., THOMPSON E.A., LINDAHL U. Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. J Biol Chem. 261:1986;3980-3986.